☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Adult Recurrent Glioblastoma
Innovent's Byvasda (Bevacizumab Biosimilar) Receive NMPA's Approval for Adult Recurrent Glioblastoma
December 28, 2020
Innovent's Byvasda (biosimilar- bevacizumab) Receives NMPA's Approval for the Treatment of Adult Recurrent Glioblastoma
December 21, 2020
Load more...
Back to Home
